SENORES
Senores Pharmaceuticals Limited
Pharmaceuticals · ₹6,544 Cr market cap
A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.
4
Tracked investors holding
6
Tracked moves
₹1,420
Share price
Latest activity
Recent moveIncreased
Renosen Pharmaceuticals Private Limited, a promoter group entity, bought 7.39 lakh shares of Senores Pharmaceuticals Limited for ₹60.01 crore at ₹812 apiece. Their shareholding after the transaction is 63.16%.
Top investors holding Senores Pharmaceuticals Limited
Plus 1 more tracked investor holding Senores Pharmaceuticals Limited. Sign in to see them all.
Sign in to view all holdersTrack smart money in Senores Pharmaceuticals Limited
Get alerted when a top investor buys or sells.
Get started